Inhalable Biologics for Treating Acute and Chronic Lung Diseases

Time: 4:30 pm
day: Day 1


  • Leverage the potential of inhalable biologics using lipid-based drug delivery vehicles such as exosomes, liposomes, and lipid nanoparticles (LNPs) for precise and effective treatment
  • Explore the innovative delivery of therapeutic microRNA via inhalation as a promising approach for treating acute lung injury (ALI) and idiopathic pulmonary fibrosis (IPF), offering targeted healing directly at the source
  • Extend the benefits of inhalation therapy beyond lung diseases, opening new avenues for treating systemic conditions like diabetes and myocardial infarction through noninvasive, focused treatments